ESC Professional Premium Access

SGLT2 inhibitors in clinical practice

Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session type: Moderated ePosters
Date: 27 August 2022
Time: 13:15 - 13:55

Congress Session

7 presentations in this session

Absolute treatment effects of novel oral antidiabetic drugs on cardiovascular mortality and hospitalization for heart failure: a meta-analysis of digitalized individual patient outcomes

Speaker: Mr G. Wolff (Duesseldorf, DE)

The gender gap in prescription pattern of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes

Speaker: Mr A. Hammer (Vienna, AT)

Pharmacological selectivity of SGLT2 inhibitors and cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis

Speaker: Doctor A. Sayour (Budapest, HU)

Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease

Speaker: Doctor D. Chipayo Gonzales (Madrid, ES)

Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes patients: a propensity score-matched study

Speaker: Mr O. Chou (Hong Kong, HK)

Characterization of the SGLT2 interaction network and its regulation by SGLT2 inhibitors: a bioinformatic analysis

Speaker: Miss A. Nowak (Warsaw, PL)

Dapagliflozin improves Myocardial Flow Reserve in patients with Type 2 Diabetes: the DAPAHEART Trial.

Speaker: Doctor D. D'amario (Rome, IT)

7 speakers from this session

Mr Georg Wolff

University Hospital Duesseldorf, Duesseldorf (Germany)
0 follower

Mr Andreas Hammer

AKH Wien, Vienna (Austria)
0 follower

Doctor Alex Ali Sayour

Semmelweis University Heart and Vascular Center, Budapest (Hungary)
0 follower

Doctor David Antonio Chipayo Gonzales

San Carlos Clinical Hospital, Madrid (Spain)
0 follower

Mr Oscar Hou In Chou

The University of Hong Kong, Hong Kong (Hong Kong)
0 follower

Miss Anna Nowak

Medical University of Warsaw, Warsaw (Poland)
0 follower

Doctor Domenico D'amario

Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome (Italy)
4 presentations
0 follower

This platform is supported by

logo Novo Nordisk